Bringing the Power of Paperless Execution to Quality and Manufacturing
The MODA-ES® Platform is the next generation MES for cell and gene therapy. Building on a wealth of domain knowledge and experience, the MODA® Platform brings together Lonza’s Cell and Gene Manufacturing Expertise and the MODA® Software Platform to create a compliant solution designed for the user. The Platform facilitates an innovative and cost effective transition from paper-based batch records to electronic record-keeping.
Compared to traditional MES approaches the MODA-ES® Platform - MES for cell & gene therapy consolidates all cell and gene therapy manufacturing batch data, and batch-related quality control data, into a single record with an easy-to-use review and approval interface for expedited product release. With data integrity compliance and traceability at its core, the solution captures trends and key quality and performance metrics, while eliminating errors associated with paper-based approaches.
By focusing on flexibility, configurability and scalability the MODA-ES® Platform-MES for cell and gene therapy is designed to provide a range of configurable options for expedited implementation and validation at an affordable price point and with a lower total cost of ownership. With a flexible, user-friendly workflow that is suitable for manufacturers of any size, the MODA-ES® Platform brings the power of MES to cell and gene therapy.
Benefits at a glance:
- Built by the end user for the end user - a flexible, cost effective MES solution to digitalize Cell Therapy manufacturing
- Combines quality and manufacturing in a single batch record
- Enable parallel processing with track and trace and maximize capacity to scale production
- Implementation team with experience in cell therapy manufacturing
- Easy configuration, implementation and validation
